Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Isolated Seizure Presentation in Seropositive Autoimmune Encephalitis: A Multi-Center Retrospective Case Series

              Author:Surti, Tapasya   Kolawole, Omolara   Habis, Ralph   Bean, Paris   Heck, Ashley   Wu, Sienna   Gupta, Rajesh   Hasbun, Rodrigo   Probasco, John   Venkatesan, Arun   

              Session Name:S7: Autoimmune Encephalitis  

              Topic:Autoimmune Neurology  

              Program Number:S7.009  

              Author Institution:University of Texas Health Science Center, Houston, Houston, TX  Johns Hopkins School of Medicine, Baltimore, MD  Walter Reed National Military Medical Center, Houston, TX  Houston Methodist Hospital, Houston, TX  Johns Hopkins Hospital, Baltimore, MD  

              RESCUE: A Proof-of-Concept Trial with Adjunct RNS60 Treatment Shows Safety, Reduced Infarct Growth, and Numerical Improvement in all Prespecified Efficacy Endpoints in Participants with Acute Ischemic Stroke

              Author:Ghosh, Supurna   Dubow, Jordan   Sutherland, Jocelyn   Baird, Grayson   Smith, Wendy   Chiu, David   Clark, Wayne   Favilla, Christopher   Ansari, Sameer   Kalmes, Andreas   Mock, Jarrad   Cook, Douglas   Madsen, Tracy   Jayaraman, Mahesh   Moldovan, Krisztina   Torabi,   

              Session Name:S25: Emerging Stroke Therapies and Risk Stratification  

              Topic:Cerebrovascular Disease and Interventional Neurology  

              Program Number:S25.007  

              Author Institution:Revalesio, Tacoma, WA  Rhode Island Hospital, Providence, RI  Houston Methodist Hospital, Houston, TX  Oregon Health Sciences Univ, Portland, OR  Revalesio Corporation, Tacoma, WA  University of California at Los Angeles, Los Angeles, CA  

              Efficacy and Safety of Autologous BCMA-directed mRNA CAR T-Cell Therapy in Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Placebo-controlled Trial

              Author:Vu, Tuan   Tekce, Hacer Durmus   Rivner, Michael   Shroff, Sheetal   Ragole, Thomas   Myers, Bennett   Pasnoor, Mamatha   Small, George   Karam, Chafic   Vullaganti, Mithila   Peltier, Amanda   Sahagian, Gregory   Feinberg, Marc   Barnett Tapia, Carolina   Siddiqi, Zaeem   Jewell, Chr   

              Session Name:S34: Updates on Myasthenia Gravis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S34.002  

              Author Institution:Augusta University, Augusta, GA  Houston Methodist Hospital, Houston, TX  University of Colorado Department of Neurology, Aurora, CO  Dent Neurologic Institute, Buffalo, NY  University of Kansas Medical Center, Kansas City, KS  ANA, Pittsburgh, PA  University of Pennsylvania, Philadelphia, PA  Tufts Medical Center, Boston, MA  Vanderbilt University, Nashville, TN  Neurology Center of Southern California, Carlsbad, CA  South Florida Neurology Ass., Boca Raton, FL  University of Toronto, Toronto, ON, Canada  University of Alberta Hospital, Edmonton, AB, Canada  Cartesian Therapeutics, Frederick, MD  Cartesian Therapeutics, Gaithersburg, MD  University of California Irvine, Orange, CA  

              Altered Myelin Lipid Homeostasis and Their Effect on Promyelinating Factor - PAK2 in PMP22 Haploinsufficiency

              Author:Hu, Bo   Pernal, Sebastian   Li, Jun   

              Session Name:S34: Updates on Myasthenia Gravis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S34.009  

              Author Institution:Houston Methodist Hospital, Houston, TX  

              Cerebral Air Embolism After Atrial Ablation: A Deadly Pathway Through an Atrio-Esophageal Fistula

              Author:Ghazanfar, Rija   Zahid, Anza   Tahir, Zabreen   Gadhia, Rajan   

              Session Name:P3: Cerebrovascular Disease and Interventional Neurology: Rare Clinical Case Presentations  

              Topic:Cerebrovascular Disease and Interventional Neurology  

              Program Number:P3.002  

              Author Institution:Houston Methodist Hospital, Houston, TX